Mak C M, Mok N S, Shum H C, Siu W K, Chong Y K, Lee H H C, Fong N C, Tong S F, Lee K W, Ching C K, Chen S P L, Cheung W L, Tso C B, Poon W M, Lau C L, Lo Y K, Tsui P T, Shum S F, Lee K C
Department of Pathology, Princess Margaret Hospital, Kwai Chung, Hong Kong.
Department of Medicine and Geriatrics, Princess Margaret Hospital, Kwai Chung, Hong Kong.
Hong Kong Med J. 2019 Feb;25(1):21-9. doi: 10.12809/hkmj187256. Epub 2019 Jan 23.
Sudden arrhythmia death syndrome (SADS) accounts for about 30% of causes of sudden cardiac death (SCD) in young people. In Hong Kong, there are scarce data on SADS and a lack of experience in molecular autopsy. We aimed to investigate the value of molecular autopsy techniques for detecting SADS in an East Asian population.
This was a two-part study. First, we conducted a retrospective 5-year review of autopsies performed in public mortuaries on young SCD victims. Second, we conducted a prospective 2-year study combining conventional autopsy investigations, molecular autopsy, and cardiac evaluation of the first-degree relatives of SCD victims. A panel of 35 genes implicated in SADS was analysed by next-generation sequencing.
There were 289 SCD victims included in the 5-year review. Coronary artery disease was the major cause of death (35%); 40% were structural heart diseases and 25% were unexplained. These unexplained cases could include SADS-related conditions. In the 2-year prospective study, 21 SCD victims were examined: 10% had arrhythmogenic right ventricular cardiomyopathy, 5% had hypertrophic cardiomyopathy, and 85% had negative autopsy. Genetic analysis showed 29% with positive heterozygous genetic variants; six variants were novel. One third of victims had history of syncope, and 14% had family history of SCD. More than half of the 11 first-degree relatives who underwent genetic testing carried related genetic variants, and 10% had SADS-related clinical features.
This pilot feasibility study shows the value of incorporating cardiac evaluation of surviving relatives and next-generation sequencing molecular autopsy into conventional forensic investigations in diagnosing young SCD victims in East Asian populations. The interpretation of genetic variants in the context of SCD is complicated and we recommend its analysis and reporting by qualified pathologists.
心律失常性猝死综合征(SADS)约占年轻人心脏性猝死(SCD)病因的30%。在香港,关于SADS的数据稀缺,且缺乏分子尸检经验。我们旨在研究分子尸检技术在东亚人群中检测SADS的价值。
本研究分为两部分。首先,我们对公共太平间进行的年轻SCD受害者尸检进行了为期5年的回顾性研究。其次,我们进行了一项为期2年的前瞻性研究,结合了传统尸检调查、分子尸检以及对SCD受害者一级亲属的心脏评估。通过下一代测序分析了一组与SADS相关的35个基因。
5年回顾性研究纳入了289例SCD受害者。冠状动脉疾病是主要死因(35%);40%为结构性心脏病,25%死因不明。这些死因不明的病例可能包括与SADS相关的情况。在为期2年的前瞻性研究中,对21例SCD受害者进行了检查:10%患有致心律失常性右室心肌病,5%患有肥厚型心肌病,85%尸检结果为阴性。基因分析显示29%存在杂合子基因变异阳性;六个变异为新发现的。三分之一的受害者有晕厥史,14%有SCD家族史。在接受基因检测的11名一级亲属中,超过一半携带相关基因变异,10%有与SADS相关的临床特征。
这项初步可行性研究表明,将存活亲属的心脏评估和下一代测序分子尸检纳入传统法医调查,对于诊断东亚人群中的年轻SCD受害者具有价值。SCD背景下基因变异的解读很复杂,我们建议由合格的病理学家进行分析和报告。